Poole Jonathan 4
4 · Evelo Biosciences, Inc. · Filed Jan 30, 2020
Insider Transaction Report
Form 4
Transactions
- Award
Stock Option (Right to Buy)
2020-01-28+106,000→ 106,000 totalExercise: $7.06Exp: 2030-01-27→ Common Stock (106,000 underlying) - Award
Stock Option (Right to Buy)
2020-01-28+48,000→ 48,000 totalExercise: $7.06Exp: 2030-01-27→ Common Stock (48,000 underlying)
Footnotes (2)
- [F1]These options will vest in forty-eight (48) substantially equal installments at the end of each monthly anniversary of January 9, 2020, subject to continued employment on such dates.
- [F2]These options will vest as to 50% of the total grant on January 9, 2022 and as to the remaining 50% on January 9, 2023.